-
Mashup Score: 2Tumor Board Tuesday 2023 - Integrity CE - 2 year(s) ago
Tumor Board Tuesdays is a regularly scheduled, Twitter-based case discussion forum led by expert faculty exploring cases in various solid tumor malignancies. The series will focus on practice application in the clinic. Experts will present recent data and focus on realistic case examples. The advantage to this format is the ability to comment and receive feedback from the experts.
Source: Integrity CECategories: Hem/Oncs, Latest HeadlinesTweet-
RT @TumorBoardTues: #PreTest Q2⃣ #TumorBoardTuesday Free #CME🔗https://t.co/GzqzvikHrp @JenniferLitton and @marijasullivan 🤔What additiona…
-
-
Mashup Score: 1Page not found - Integrity CE - 2 year(s) ago
It looks like nothing was found at this location. Maybe try a search? Search for:
Source: Integrity CECategories: Hem/Oncs, Latest HeadlinesTweet-
RT @TumorBoardTues: #TumorBoardTuesday https://t.co/63osUKLysL So, if your 2022🇺🇸taxes are all submitted, then before @JenniferLitton & @…
-
-
Mashup Score: 4@TumorBoardTues Case Conversations_2022 - Integrity CE - 2 year(s) ago
Evaluation Previous Conversations PROVIDER STATEMENT Provided by Integrity Continuing Education, Inc. and Tumor Board Tuesday. MODERATOR Michael J. Pishvaian, MD, PhD Associate Professor, Department of Oncology Director of the Gastrointestinal, Development Therapeutics, and Clinical Research Programs at the NCR Kimmel Cancer Center at Sibley Memorial Hospital Johns Hopkins University School of…
Source: Integrity CECategories: Latest Headlines, Oncologists2Tweet-
RT @TumorBoardTues: #PreTest Q1️⃣ #TumorBoardTuesday Free #CME🔗https://t.co/63osUKLysL LIVE from🇬🇧TONIGHT at 8pm ET/1am BT when @tompowles1…
-
-
Mashup Score: 0@TumorBoardTues Case Conversations_2022 - Integrity CE - 2 year(s) ago
Evaluation Previous Conversations PROVIDER STATEMENT Provided by Integrity Continuing Education, Inc. and Tumor Board Tuesday. MODERATOR Michael J. Pishvaian, MD, PhD Associate Professor, Department of Oncology Director of the Gastrointestinal, Development Therapeutics, and Clinical Research Programs at the NCR Kimmel Cancer Center at Sibley Memorial Hospital Johns Hopkins University School of…
Source: Integrity CECategories: Hem/Oncs, Latest HeadlinesTweet-
RT @TumorBoardTues: #PreTest Q2️⃣ #TumorBoardTuesday #CME🔗 https://t.co/63osUKLysL 🤔What 2L would you pick for your 75yo pt with MIBC & Cr…
-
RT @TumorBoardTues: #PreTest Q1️⃣ #TumorBoardTuesday Free #CME🔗https://t.co/63osUKLysL LIVE from🇬🇧TONIGHT at 8pm ET/1am BT when @tompowles1…
-
-
Mashup Score: 3@TumorBoardTues Case Conversations_2022 - Integrity CE - 2 year(s) ago
Evaluation Previous Conversations PROVIDER STATEMENT Provided by Integrity Continuing Education, Inc. and Tumor Board Tuesday. MODERATOR Michael J. Pishvaian, MD, PhD Associate Professor, Department of Oncology Director of the Gastrointestinal, Development Therapeutics, and Clinical Research Programs at the NCR Kimmel Cancer Center at Sibley Memorial Hospital Johns Hopkins University School of…
Source: Integrity CECategories: Hem/Oncs, Latest HeadlinesTweet-
RT @TumorBoardTues: #PreTest Q 1️⃣ #TumorBoardTuesday Free #CME 🔗 https://t.co/63osUKLysL We’re back to GI oncology this week with @shafia…
-
RT @TumorBoardTues: 👉🏽 #CME https://t.co/63osUKLysL #GITwitter Let’s try this again! One way #TumorBoardTuesday gathers input is with pol…
-
-
Mashup Score: 1@TumorBoardTues Case Conversations_2022 - Integrity CE - 2 year(s) ago
Evaluation Previous Conversations PROVIDER STATEMENT Provided by Integrity Continuing Education, Inc. and Tumor Board Tuesday. MODERATOR Michael J. Pishvaian, MD, PhD Associate Professor, Department of Oncology Director of the Gastrointestinal, Development Therapeutics, and Clinical Research Programs at the NCR Kimmel Cancer Center at Sibley Memorial Hospital Johns Hopkins University School of…
Source: Integrity CECategories: Hem/Oncs, Latest HeadlinesTweet-
RT @TumorBoardTues: #TumorBoardTuesday 💬Join us here on #TumorBoardTuesday! 👉🏽 https://t.co/63osUKM6ij 👈🏼 One way #TumorBoardTuesday gath…
-
-
Mashup Score: 1@TumorBoardTues Case Conversations_2022 - Integrity CE - 2 year(s) ago
Evaluation Previous Conversations PROVIDER STATEMENT Provided by Integrity Continuing Education, Inc. and Tumor Board Tuesday. MODERATOR Michael J. Pishvaian, MD, PhD Associate Professor, Department of Oncology Director of the Gastrointestinal, Development Therapeutics, and Clinical Research Programs at the NCR Kimmel Cancer Center at Sibley Memorial Hospital Johns Hopkins University School of…
Source: Integrity CECategories: Hem/Oncs, Latest HeadlinesTweet-
RT @TumorBoardTues: #TumorBoardTuesday 👉🏽#CME https://t.co/63osUKM6ij One way #TumorBoardTuesday gathers input is with polls📊, so before…
-
-
Mashup Score: 2@TumorBoardTues Case Conversations_2022 - Integrity CE - 2 year(s) ago
Evaluation Previous Conversations PROVIDER STATEMENT Provided by Integrity Continuing Education, Inc. and Tumor Board Tuesday. MODERATOR Michael J. Pishvaian, MD, PhD Associate Professor, Department of Oncology Director of the Gastrointestinal, Development Therapeutics, and Clinical Research Programs at the NCR Kimmel Cancer Center at Sibley Memorial Hospital Johns Hopkins University School of…
Source: Integrity CECategories: Hem/Oncs, Latest HeadlinesTweet-
RT @DAielloMD: #PostTest Q2️⃣ #TumorBoardTuesday 👉🏽Free CME (AMA & MOC) 🔗 https://t.co/sC736tVqG4 🧐What’s cause of discordant 🧬findings btw…
-
-
Mashup Score: 1@TumorBoardTues Case Conversations_2022 - Integrity CE - 2 year(s) ago
Evaluation Previous Conversations PROVIDER STATEMENT Provided by Integrity Continuing Education, Inc. and Tumor Board Tuesday. MODERATOR Michael J. Pishvaian, MD, PhD Associate Professor, Department of Oncology Director of the Gastrointestinal, Development Therapeutics, and Clinical Research Programs at the NCR Kimmel Cancer Center at Sibley Memorial Hospital Johns Hopkins University School of…
Source: Integrity CECategories: Hem/Oncs, Latest HeadlinesTweet-
RT @TumorBoardTues: #TumorBoardTuesday #NSCLC @DrSteveMartin @DAielloMD 👉🏽#CME🔗 https://t.co/63osUKLysL And b4⃣ the discussion on Tuesday…
-
-
Mashup Score: 1@TumorBoardTues Case Conversations_2022 - Integrity CE - 2 year(s) ago
Evaluation Previous Conversations PROVIDER STATEMENT Provided by Integrity Continuing Education, Inc. and Tumor Board Tuesday. MODERATOR Michael J. Pishvaian, MD, PhD Associate Professor, Department of Oncology Director of the Gastrointestinal, Development Therapeutics, and Clinical Research Programs at the NCR Kimmel Cancer Center at Sibley Memorial Hospital Johns Hopkins University School of…
Source: Integrity CECategories: Hem/Oncs, Latest HeadlinesTweet-
RT @TumorBoardTues: #TumorBoardTuesday 👉🏽#CME🔗 https://t.co/63osUKM6ij 😀We are so glad to have you join into the discussion🗣️with @Narjust…
-
RT @TumorBoardTues: #PreTest Q1⃣ #TumorBoardTuesday Free #CME🔗https://t.co/GzqzvikHrp @JenniferLitton and @marijasullivan 🤔Prior to select…